Apex

Apex Healthcare Berhad (“Apex”) is a leading Southeast Asian pharmaceutical company with deep capabilities across branded generics, consumer health products, and distribution services. Headquartered in Singapore, with an expanding presence across Malaysia and Singapore, Apex develops, manufactures, markets and distributes a broad portfolio of pharmaceutical and consumer healthcare products that serve both prescription and over the counter segments. The company is recognised for its high-quality branded generics Xepa, and longstanding reputation in community healthcare, supported by an integrated supply chain and extensive distribution network.

Apex operates across the full value chain — from R&D and manufacturing to sales, marketing, warehousing and distribution — enabling it to deliver reliable, affordable, and quality assured medicine to clinics, pharmacies, and hospitals throughout the region.

Who we partnered with

65 Equity Partners is working closely with our shareholder partners and Apex’s seasoned management team to support the company’s next phase of growth. We aim to leverage our global and Singapore network to help Apex strengthen its presence in Singapore as a strategic hub for regional expansion and as an anchor for their value-creation strategy.

What attracted us to the business

Apex’s mission aligns strongly with our thematic focus on essential healthcare, quality generics, and broad-based access to medical products across Asia. The company’s robust manufacturing and distribution capabilities provide a scalable platform for product expansion and regional growth into the wider ASEAN region. Combined with a high quality, execution focused management team, and a clear pathway to unlock further value through capacity enhancements, portfolio deepening and commercial strengthening, Apex represents an opportunity to support an essential healthcare champion on its growth journey.

Our value creation strategy

65 Equity Partners will work closely with our partners to drive both organic expansion and strategic M&A activities, with the goal of building a leading regional integrated pharmaceutical and consumer health platform anchored in Singapore. Our value creation strategy focuses on accelerating R&D pipelines and strengthening external partnerships to bring new drugs to market faster; expanding consumer health presence by leveraging Apex’s strong distribution network; strengthening Apex’s regional presence in Southeast Asia; and driving operational excellence across business segments.

Website: https://apexhealthcare.com.my/#home